Cargando…
Colorectal Cancer Organoid–Stroma Biobank Allows Subtype-Specific Assessment of Individualized Therapy Responses
In colorectal cancers, the tumor microenvironment plays a key role in prognosis and therapy efficacy. Patient-derived tumor organoids (PDTO) show enormous potential for preclinical testing; however, cultured tumor cells lose important characteristics, including the consensus molecular subtypes (CMS)...
Autores principales: | Farin, Henner F., Mosa, Mohammed H., Ndreshkjana, Benardina, Grebbin, Britta M., Ritter, Birgit, Menche, Constantin, Kennel, Kilian B., Ziegler, Paul K., Szabó, Lili, Bollrath, Julia, Rieder, Dietmar, Michels, Birgitta E., Kress, Alena, Bozlar, Müge, Darvishi, Tahmineh, Stier, Sara, Kur, Ivan-Maximilano, Bankov, Katrin, Kesselring, Rebecca, Fichtner-Feigl, Stefan, Brüne, Bernhard, Goetze, Thorsten O., Al-Batran, Salah-Eddin, Brandts, Christian H., Bechstein, Wolf O., Wild, Peter J., Weigert, Andreas, Müller, Susanne, Knapp, Stefan, Trajanoski, Zlatko, Greten, Florian R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551667/ https://www.ncbi.nlm.nih.gov/pubmed/37489084 http://dx.doi.org/10.1158/2159-8290.CD-23-0050 |
Ejemplares similares
-
Cancer-Associated Fibroblasts in Inflammation and Antitumor Immunity
por: Kennel, Kilian B., et al.
Publicado: (2023) -
Perspectives on the Management of Oligometastatic Disease in Esophago-Gastric Cancer
por: Goetze, Thorsten Oliver, et al.
Publicado: (2022) -
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses
por: Michels, Birgitta E., et al.
Publicado: (2019) -
Multimodal Treatment Strategies in Esophagogastric Junction Cancer: a Western Perspective
por: Goetze, Thorsten Oliver, et al.
Publicado: (2019) -
Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC) – a phase III study of the German registry of incidental gallbladder carcinoma platform (GR)– the AIO/ CALGP/ ACO- GAIN-trial –
por: Goetze, Thorsten O., et al.
Publicado: (2020)